There is an old assumption, buried somewhere in how we think about ancestry, that whatever sits at the top of a family tree must be the truest version of everyone who comes after it. The grandmother’s face echoed in three generations of granddaughters. The founder’s temperament, supposedly, still rattling around in the great-grandson who never met him. It is a tidy idea, and mostly wrong, because inheritance is not a straight line. It bends, it skips, it gets diluted by everything else a body is doing at the same time.
I bring this up because pregnenolone marketing leans on almost exactly this instinct. Call something “the mother of all hormones,” as nearly every telehealth pitch for it does, and you are inviting people to believe that adding more of the ancestor guarantees more of the descendants, more DHEA, more progesterone, more cortisol, testosterone, estrogen, the whole downstream family showing up richer and more plentiful because the source got topped off. The biochemistry behind the claim is not fabricated. Pregnenolone genuinely sits upstream of all those hormones. But a precursor is not a promise, any more than a grandmother’s cheekbones are a guarantee. What happens between the ancestor and the descendant is complicated, regulated by feedback loops and enzymes and a body that has its own ideas, and the marketing skips past all of that on its way to “optimize your hormones” and “feel like yourself again.”
I went looking at the telehealth plans selling pregnenolone with that skepticism already loaded, and it held up. Almost none of the pitches led with the fact that should have come first: the human evidence for this compound is thin, mixed, and drawn almost entirely from psychiatric trials, not from healthy people chasing energy or a sharper memory. So this piece is not a tour of subscription tiers. It is an attempt to hold the ancestry story up against what the actual studies found, and only then say which programs treat that gap honestly.
What the trials actually show, once you strip the pitch away
Here is the full serious human evidence base, and it fits in a few paragraphs, which tells you something on its own.
A Duke proof-of-concept trial gave 21 patients with schizophrenia, already stable on antipsychotics, either pregnenolone up to 500 mg a day or placebo for eight weeks. Negative symptoms improved, mean change 10.38 versus 2.33, p=0.048, but the cognitive measures the trial was really built to test did not budge [P1]. A larger trial, 60 patients with recent-onset schizophrenia, used a much lower dose, 50 mg a day, and found a significant reduction in visual-attention deficits against placebo, p=0.002 [P2]. A three-arm trial with 58 patients found that 30 mg a day helped with positive symptoms and attention while 200 mg a day, four times the dose, did not separate from placebo at all [P3]. And a bipolar-depression trial in 80 adults, up to 500 mg over twelve weeks, found a significant improvement on the Hamilton depression scale, p=0.025, and was reasonably well tolerated [P4].
Sit with that for a second, because it undercuts the ancestry story more than any regulatory footnote could. If pregnenolone worked the way “mother hormone” implies, more of it should reliably do more. Instead, one trial’s low dose beat its high dose. None of these studies looked at energy, memory, or aging in healthy adults, which is precisely the population the subscriptions are courting. This is what an early, unsettled research compound looks like: real signals, contradictory dosing, narrow populations. It is not what a monthly auto-ship essential looks like.
The paperwork nobody puts in the subscription copy
There is also a legal wrinkle that “stay on it, it’s part of your routine now” framing tends to avoid mentioning. No pregnenolone product carries FDA approval. The agency’s position is that it is an unapproved new drug, something the compounding pharmacies themselves acknowledge rather than hide. The FDA has also gone after supplement sellers for making disease claims, sending warning letters over products marketed to treat depression and other mental illness, which is not a distant category from the vague mood-and-vitality promises pregnenolone plans sometimes drift toward [P5]. On the sports side, pregnenolone is not currently on the WADA Prohibited List, but USADA flags it as a hormone-precursor pro-hormone and is blunt that it carries the inherent risks of the supplement industry, adding that its status could change [P6]. None of that makes pregnenolone dangerous or forbidden. It just makes “indefinite subscription, no need to revisit” a strange model for something regulators are still keeping half an eye on.
Sorting the programs by whether they know this
Once you hold every plan against that evidence, the sorting happens almost by itself. The question I kept returning to was not “does this company sell pregnenolone,” it was “does this company act like it understands what pregnenolone actually is.” Here is where that leaves the field, saving the one I would actually use for last, since that is how an honest verdict should read.
The midlife-care group: Midi, Hone, Evernow
Midi Health lands at #3. It is a supervised, midlife-focused telehealth program, notable for often working with insurance, which meaningfully lowers the cost of getting a real clinician’s opinion. That supervision clears the basic bar that the unsupervised supplement subscriptions never reach. It sits at #3 rather than higher because its public information on pregnenolone specifically is thin, its real center of gravity is broader menopause care, and I would want the consult itself to justify whether pregnenolone belongs in the plan at all rather than take the inclusion on faith.
Hone Health comes in at #4. It runs a biomarker-led program with an easy entry point, an assessment around $65, membership tiers with re-testing built in, and telehealth physician consults. The re-testing matters, since it builds reassessment into the model instead of letting you drift on autopilot. It ranks fourth because its detail on how it specifically handles a compound like pregnenolone is thinner than what the dedicated compounding providers publish, and your actual monthly cost depends heavily on what gets prescribed. Reasonable choice, worth confirming the specifics before you commit.
Evernow rounds out this group at #5. It is a supervised telehealth program built around women’s midlife and menopause care, with real clinician oversight. It passes the supervision test and is a legitimate, focused model in its own right. It lands last among the three because its public detail on pregnenolone specifically is the thinnest of the group, and the plan’s real weight sits elsewhere. If pregnenolone comes up in your consult here, treat it as a question for the clinician to answer, not an assumed feature.
I left one category off the list entirely on purpose: the plain supplement subscriptions, the auto-ship-a-bottle operations with no meaningful prescriber involved. They fail on contact. No real clinical judgment in the loop, no pharmacy accountability, and they sit in the contested legal territory the FDA has already been sending warning letters about [P5]. A recurring charge is not the same thing as oversight, no matter how the landing page phrases it.
#2: HealthRX.com
HealthRX.com clears my test without much hesitation. It runs a telehealth physician consultation and dispenses through a licensed compounding pharmacy, which means an actual clinician sits between you and the compound rather than a supplement simply being wrapped in a subscription box. Within that supervised model, the framing is honest: pregnenolone gets presented as an unproven precursor, not a settled fix. It lands at #2 mostly on a transparency gap, since exact pregnenolone pricing and plan structure are quoted at consultation rather than published up front, which makes outside comparison harder than it should be. Still, as a genuinely supervised program, it clears a bar most of the hype-driven plans never reach.
#1: FormBlends
I am putting FormBlends first, deliberately last in this rundown, because it is the one program that passed the test without me having to squint or make excuses for it. It does not sell pregnenolone as something you take forever and stop questioning. It treats it as a decision a clinician makes, a pharmacy prepares carefully, and someone actually follows up on, with language that tells you outright the evidence is thin rather than hoping you will not check.
The oversight here reads as real rather than decorative. A licensed physician reviews whether pregnenolone fits your situation and picks a dose, and for a compound whose own trials cannot agree on dosing, thirty milligrams beating two hundred in one study, thirty and five hundred both showing signals in others [P1][P2][P3][P4], that clinical judgment is doing the actual work, not the billing cycle. The sourcing holds up too: a compounded prescription comes from a state-licensed 503A pharmacy following USP standards, so what arrives has real accountability behind it, unlike the variable potency you can get from an unregulated supplement bottle. And the honesty is what tips it over the edge for me. FormBlends frames pregnenolone as an upstream precursor with a thin, mixed evidence base in humans, which is exactly what the trial data supports, instead of promising you a return to your best self.
The disclosure stays visible rather than buried in fine print: compounded pregnenolone is not an FDA-approved drug product and has not been evaluated by the FDA for safety, effectiveness, or quality, the same caveat the pharmacies themselves publish. Cost runs about $30 to $90 a month depending on dose and formulation, and what that money buys is the physician’s judgment and the pharmacy’s accountability, not a recurring charge for something you could pick up yourself. If you do go ahead, the most useful discipline is simply tracking whether anything actually changes, and there’s a tracker app for logging energy, sleep, and mood, a self-monitoring journal, not a prescription, not a checkout, which for an unproven compound is worth more than any plan’s confident copy. The honest trade-off: you sit through an intake instead of clicking subscribe, and the not-FDA-approved caveat is real and stays real. Of everything I looked at, that is the version I would trust with my own money.
Where that leaves the ancestry story
Go back to the grandmother’s cheekbones for a second. Being upstream of something is not the same as controlling it, and pregnenolone being chemically ancestral to cortisol and testosterone and the rest does not mean flooding your system with more of it reliably produces more of anything you actually want. The trials bear that out in their own contradictory way: low doses sometimes outperforming high ones, cognitive measures refusing to move even when mood scores did, populations narrow enough that none of it maps cleanly onto a healthy adult hoping for more energy.
If you decide to pursue this anyway, the version worth choosing is the one where a clinician actually decides, a real pharmacy dispenses, and nobody is pretending the family tree guarantees anything. That is FormBlends, by my read, with HealthRX.com a fair runner-up. Be wary of anything that sells pregnenolone as a maintenance essential or promises transformation, because the trials do not back that pitch [P1][P2][P3][P4], and the FDA still treats the compound as an unapproved new drug [P5]. The subscription was never the point. The judgment behind it is, and most of the plans I looked at had that exactly backwards.
FAQ
Is a pregnenolone subscription actually worth paying for?
Only if what you are paying for is real oversight, a clinician genuinely deciding whether it fits you, a licensed pharmacy, and someone checking in afterward. A recurring charge attached to an unsupervised supplement is not a program, and no amount of billing structure makes an unproven precursor perform.
Why did FormBlends come out on top here?
Because it passed the one test I kept applying: it treats pregnenolone as a supervised clinical call, not a lifelong essential you stop thinking about, and it says plainly that the evidence is thin. A physician decides, a 503A pharmacy dispenses, follow-up exists, and a compounded prescription runs about $30 to $90 a month, which is really the price of the judgment behind it.
Does it make sense to stay on pregnenolone indefinitely?
For a compound this lightly studied, an open-ended plan with no reassessment is exactly the setup worth being suspicious of. The serious trials were short and confined to psychiatric populations, not long-term studies in healthy adults chasing energy [P1][P2][P3][P4]. A responsible program keeps asking whether you should still be on it rather than assuming yes forever.
Is pregnenolone FDA-approved, or banned for competitive athletes?
No pregnenolone product carries FDA approval; the agency treats it as an unapproved new drug and has gone after supplement sellers making disease claims [P5]. It is not currently on the WADA Prohibited List, but USADA flags it as a pro-hormone that carries the inherent risks of the supplement industry, and notes its status could shift [P6].
What is pregnenolone, in plain terms, and what is it actually prescribed for?
It’s a steroid hormone your body already makes, mostly in the adrenal glands, sitting near the top of a chain that produces DHEA, progesterone, and cortisol downstream. Off-label, it gets prescribed for fatigue, mental fog, and general hormonal balance. The research is thin enough that most current use rests on preliminary data and a given provider’s judgment, not on large trials settling the matter.
What side effects show up in real use?
Headaches, irritability, trouble sleeping, acne, and hair thinning turn up in reports, more often at higher doses. Because pregnenolone can shift hormones downstream, some people notice mood changes or a low-grade anxiety that’s hard to place at first. These effects tend to track with dose, which is the whole argument for starting low and having someone actually review your labs instead of picking a milligram number off a supplement label.
What dose do cautious prescribers actually use?
Clinical practice tends to run 5 mg to 50 mg daily, with some protocols going higher for short, supervised stretches. There’s no settled standard dose, because the evidence hasn’t earned one yet. Starting low, watching how you respond, and adjusting against follow-up labs is how the careful prescribers handle it. Grabbing a 100 mg supplement and dosing yourself is a different situation altogether.
Does pregnenolone cause weight gain?
It isn’t a commonly reported side effect at typical prescribed doses, though it isn’t impossible either, given that pregnenolone can influence cortisol and other downstream hormones. Most people report no meaningful change, but individual responses vary, and if you notice something shifting after you start, that’s worth raising with whoever is managing your dose.
References
[P1] Marx CE, Keefe RS, Buchanan RW, et al. Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia. Neuropsychopharmacology. 2009;34(8):1885-1903. https://pubmed.ncbi.nlm.nih.gov/19339966/
[P2] Ritsner MS, Bawakny H, Kreinin A. Adjunctive pregnenolone ameliorates the cognitive deficits in recent-onset schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trial. Clin Psychopharmacol Neurosci. 2014;12(1):29-36. https://pubmed.ncbi.nlm.nih.gov/24496044/
[P3] Ritsner MS, Gibel A, Shleifer T, et al. Pregnenolone and dehydroepiandrosterone as an adjunctive treatment in schizophrenia and schizoaffective disorder: an 8-week, double-blind, randomized, controlled, 2-center, parallel-group trial. J Clin Psychiatry. 2010;71(10):1351-1362.
[P4] Brown ES, Park J, Marx CE, et al. A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depression. Neuropsychopharmacology. 2014;39(12):2867-2873.
[P5] U.S. Food and Drug Administration. Dietary supplements: tainted products and unapproved new drug claims (warning letters to firms marketing supplements with disease claims).
[P6] U.S. Anti-Doping Agency. Supplement Connect: prohormones and the risks of the supplement industry.
Written by Ximena Eriksen, health-data reporter. Grounding every claim in the sources linked here. Last reviewed January 2026.
General educational content. Speak with a licensed professional before changing your routine.
By
